StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$2.01+0.03 (+1.52%)

Close on Nov 13, 2026Market cap $79.29MP/E –Yield –

Earnings

Sera Prognostics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 17, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$42.00K
EPS, Q3 FY2026
-$0.16
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Sera Prognostics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 17, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close$42.00K–-$0.16Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026after the close$30.00K+76.5%-$0.18Release
Q1 FY2026ended Mar 31, 2026May 6, 2026after the close$14.00K-63.2%–Release
Q4 FY2025ended Dec 31, 2025Mar 18, 2026after the close$10.00K-58.3%–Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025after the close–––Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025after the close$17.00K-29.2%-$0.16Release
Q1 FY2025ended Mar 31, 2025May 7, 2025after the close$38.00K-2.6%–Release
Q4 FY2024ended Dec 31, 2024Mar 19, 2025after the close$24.00K-41.5%-$0.25Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024after the close–––Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024after the close$24.00K-80.5%-$0.25Release
Q1 FY2024ended Mar 31, 2024May 8, 2024after the close$39.00K-61.0%-$0.25Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Sera Prognostics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Sera Prognostics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Sera Prognostics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. Results
  5. Results
  6. Update
  7. Update
  8. Update
  9. Results
  10. Update
  11. Results
  12. Update
  13. Results
  14. Results
  15. Update

See a number that looks wrong?